| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH2 TDRD9 CENPE ATAD5 CLPX ACSL1 MYO3A MYO3B AFG3L2 KIF28P DNAH5 MYO1H CHD9 BTAF1 TOP6BL RFC1 RFC2 CHD5 MACF1 MYH15 | 1.76e-06 | 614 | 190 | 20 | GO:0140657 |
| GeneOntologyMolecularFunction | microtubule minus-end binding | 9.99e-06 | 15 | 190 | 4 | GO:0051011 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.74e-05 | 118 | 190 | 8 | GO:0003774 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 2.88e-05 | 38 | 190 | 5 | GO:0000146 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | SMG1 TTK CDKL5 MYO3A MYO3B TSSK3 MAP3K6 MAPK14 MTOR MAST1 PRKDC MAST3 SBK3 | 4.70e-05 | 363 | 190 | 13 | GO:0106310 |
| GeneOntologyMolecularFunction | actin filament binding | MYH2 ACTN3 MYO3A MYO1H CAMSAP3 MICALL2 EGFR MACF1 MYH15 FSCN1 | 6.61e-05 | 227 | 190 | 10 | GO:0051015 |
| GeneOntologyMolecularFunction | DNA clamp unloader activity | 9.01e-05 | 2 | 190 | 2 | GO:0061860 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | SMG1 TTK CDKL5 MYO3A MYO3B TSSK3 MAP3K6 MAPK14 EGFR MTOR MAST1 PRKDC MAST3 SBK3 | 9.90e-05 | 446 | 190 | 14 | GO:0004674 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYH2 CENPE TRPC6 ACTN3 TUBGCP4 ACE MYO3A HAUS4 ANKRD2 MYO3B KIF28P CORO7 RARA MYO1H CAMSAP3 GRIA2 TPGS1 MICALL2 EGFR MAST1 MACF1 MYH15 FSCN1 HTT | 1.26e-04 | 1099 | 190 | 24 | GO:0008092 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | TDRD9 ATAD5 RGS11 CLPX TUFM AFG3L2 KIF28P ATL2 DNAH5 RAB12 ENTPD7 CHD9 BTAF1 RFC1 RFC2 GFM2 CHD5 MACF1 MMUT | 1.58e-04 | 775 | 190 | 19 | GO:0017111 |
| GeneOntologyMolecularFunction | actin binding | MYH2 TRPC6 ACTN3 ACE MYO3A MYO3B CORO7 MYO1H CAMSAP3 MICALL2 EGFR MACF1 MYH15 FSCN1 | 2.08e-04 | 479 | 190 | 14 | GO:0003779 |
| GeneOntologyMolecularFunction | protein kinase activity | SMG1 TTK CDKL5 MYO3A MYO3B TSSK3 ALK MAP3K6 MAPK14 EGFR MTOR MAST1 PRKDC PCK1 MAST3 SBK3 | 2.09e-04 | 600 | 190 | 16 | GO:0004672 |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 2.16e-04 | 127 | 190 | 7 | GO:0008094 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | TDRD9 ATAD5 RGS11 CLPX TUFM AFG3L2 KIF28P ATL2 DNAH5 RAB12 ENTPD7 CHD9 BTAF1 RFC1 RFC2 GFM2 CHD5 MACF1 MMUT | 4.26e-04 | 839 | 190 | 19 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | TDRD9 ATAD5 RGS11 CLPX TUFM AFG3L2 KIF28P ATL2 DNAH5 RAB12 ENTPD7 CHD9 BTAF1 RFC1 RFC2 GFM2 CHD5 MACF1 MMUT | 4.32e-04 | 840 | 190 | 19 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | TDRD9 ATAD5 RGS11 CLPX TUFM AFG3L2 KIF28P ATL2 DNAH5 RAB12 ENTPD7 CHD9 BTAF1 RFC1 RFC2 GFM2 CHD5 MACF1 MMUT | 4.32e-04 | 840 | 190 | 19 | GO:0016818 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | SMG1 HK2 TTK CDKL5 MYO3A MYO3B TSSK3 ALK MAP3K6 MAPK14 EGFR MTOR MAST1 PRKDC PCK1 MAST3 SBK3 | 4.54e-04 | 709 | 190 | 17 | GO:0016773 |
| GeneOntologyMolecularFunction | kinase activity | SMG1 HK2 TTK CDKL5 MYO3A MYO3B TSSK3 ALK MAP3K6 MAPK14 EGFR MTOR MAST1 PRKDC PCK1 MAST3 SBK3 | 1.04e-03 | 764 | 190 | 17 | GO:0016301 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | TDRD9 ATAD5 CLPX AFG3L2 KIF28P DNAH5 CHD9 BTAF1 RFC1 RFC2 CHD5 MACF1 | 1.10e-03 | 441 | 190 | 12 | GO:0016887 |
| GeneOntologyMolecularFunction | kinetochore binding | 1.32e-03 | 6 | 190 | 2 | GO:0043515 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | TDRD9 ATAD5 TRUB1 TSEN34 TRMT5 SMG6 LARS1 FARSB CHD9 PIWIL2 BTAF1 TOP6BL RFC1 RFC2 CHD5 | 1.33e-03 | 645 | 190 | 15 | GO:0140640 |
| GeneOntologyBiologicalProcess | circadian rhythm | MYCBP2 UTS2 SPSB4 PIWIL2 HUWE1 CARTPT EGFR MTOR MTTP CCAR2 PRKDC | 1.72e-05 | 248 | 187 | 11 | GO:0007623 |
| GeneOntologyBiologicalProcess | peptidyl-serine phosphorylation | SMG1 TTK MYO3A MYO3B OSM MAPK14 EGFR MTOR MAST1 PRKDC PCK1 MAST3 | 2.50e-05 | 307 | 187 | 12 | GO:0018105 |
| GeneOntologyBiologicalProcess | peptidyl-serine modification | SMG1 TTK MYO3A MYO3B OSM MAPK14 EGFR MTOR MAST1 PRKDC PCK1 MAST3 | 3.64e-05 | 319 | 187 | 12 | GO:0018209 |
| Domain | ARM-type_fold | SMG1 TRIP12 ITPR1 NCAPD2 UTP20 ARMC6 TNPO2 MROH2A PKP4 BTAF1 HUWE1 MROH1 MTOR ELMO2 EIF5 PRKDC AP4B1 HTT | 1.33e-08 | 339 | 191 | 18 | IPR016024 |
| Domain | ARM-like | SMG1 TRIP12 NCAPD2 UTP20 ARMC6 TNPO2 MROH2A PKP4 BTAF1 HUWE1 MROH1 MTOR ELMO2 PRKDC AP4B1 HTT | 1.92e-08 | 270 | 191 | 16 | IPR011989 |
| Domain | HEAT_REPEAT | 3.85e-08 | 70 | 191 | 9 | PS50077 | |
| Domain | HEAT | 1.28e-07 | 58 | 191 | 8 | IPR000357 | |
| Domain | - | TRIP12 NCAPD2 UTP20 ARMC6 TNPO2 PKP4 BTAF1 MROH1 MTOR ELMO2 PRKDC AP4B1 HTT | 4.92e-07 | 222 | 191 | 13 | 1.25.10.10 |
| Domain | HEAT | 5.41e-07 | 48 | 191 | 7 | PF02985 | |
| Domain | FATC | 1.04e-05 | 5 | 191 | 3 | PF02260 | |
| Domain | FAT | 2.06e-05 | 6 | 191 | 3 | PS51189 | |
| Domain | FATC | 2.06e-05 | 6 | 191 | 3 | PS51190 | |
| Domain | FATC_dom | 2.06e-05 | 6 | 191 | 3 | IPR003152 | |
| Domain | PIK_FAT | 2.06e-05 | 6 | 191 | 3 | IPR014009 | |
| Domain | FATC | 2.06e-05 | 6 | 191 | 3 | SM01343 | |
| Domain | Kinase-like_dom | SMG1 TTK CDKL5 MYO3A MYO3B TSSK3 ALK CHD9 MAP3K6 MAPK14 EGFR MTOR MAST1 MACF1 PRKDC MAST3 SBK3 | 4.37e-05 | 542 | 191 | 17 | IPR011009 |
| Domain | LRP5/6 | 1.04e-04 | 2 | 191 | 2 | IPR017049 | |
| Domain | ATPase_AAA_core | 2.24e-04 | 54 | 191 | 5 | IPR003959 | |
| Domain | Ldl_recept_b | 3.53e-04 | 14 | 191 | 3 | PF00058 | |
| Domain | LDLRB | 3.53e-04 | 14 | 191 | 3 | PS51120 | |
| Domain | zf-RING_UBOX | 3.87e-04 | 34 | 191 | 4 | PF13445 | |
| Domain | Znf-RING_LisH | 3.87e-04 | 34 | 191 | 4 | IPR027370 | |
| Domain | PI3/4_kinase_CS | 4.38e-04 | 15 | 191 | 3 | IPR018936 | |
| Domain | LY | 4.38e-04 | 15 | 191 | 3 | SM00135 | |
| Domain | LDLR_classB_rpt | 4.38e-04 | 15 | 191 | 3 | IPR000033 | |
| Domain | P-loop_NTPase | MYH2 TDRD9 CENPE ATAD5 CLPX TUFM MYO3A MYO3B AFG3L2 DLG3 ATL2 DNAH5 RAB12 CHD9 BTAF1 RFC1 RFC2 GFM2 CHD5 MYH15 | 4.46e-04 | 848 | 191 | 20 | IPR027417 |
| Domain | - | 5.34e-04 | 16 | 191 | 3 | 1.10.1070.11 | |
| Domain | PI3Kc | 5.34e-04 | 16 | 191 | 3 | SM00146 | |
| Domain | Myosin_head_motor_dom | 5.96e-04 | 38 | 191 | 4 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 5.96e-04 | 38 | 191 | 4 | PS51456 | |
| Domain | Myosin_head | 5.96e-04 | 38 | 191 | 4 | PF00063 | |
| Domain | MYSc | 5.96e-04 | 38 | 191 | 4 | SM00242 | |
| Domain | DUF1908 | 6.16e-04 | 4 | 191 | 2 | PF08926 | |
| Domain | MA_Ser/Thr_Kinase_dom | 6.16e-04 | 4 | 191 | 2 | IPR015022 | |
| Domain | MAST_pre-PK_dom | 6.16e-04 | 4 | 191 | 2 | IPR023142 | |
| Domain | - | 6.16e-04 | 4 | 191 | 2 | 1.20.1480.20 | |
| Domain | TPR-like_helical_dom | 6.78e-04 | 233 | 191 | 9 | IPR011990 | |
| Domain | PI3_PI4_kinase | 7.67e-04 | 18 | 191 | 3 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 7.67e-04 | 18 | 191 | 3 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 7.67e-04 | 18 | 191 | 3 | PS00916 | |
| Domain | PI3/4_kinase_cat_dom | 7.67e-04 | 18 | 191 | 3 | IPR000403 | |
| Domain | PI3_4_KINASE_3 | 7.67e-04 | 18 | 191 | 3 | PS50290 | |
| Domain | - | 1.24e-03 | 46 | 191 | 4 | 4.10.400.10 | |
| Domain | - | 1.34e-03 | 207 | 191 | 8 | 1.25.40.10 | |
| Domain | LDLRA_1 | 1.45e-03 | 48 | 191 | 4 | PS01209 | |
| Domain | RIH_assoc-dom | 1.52e-03 | 6 | 191 | 2 | IPR013662 | |
| Domain | DNA_pol3_clamp-load_cplx_C | 1.52e-03 | 6 | 191 | 2 | IPR008921 | |
| Domain | Ins145_P3_rec | 1.52e-03 | 6 | 191 | 2 | PF08709 | |
| Domain | RIH_assoc | 1.52e-03 | 6 | 191 | 2 | PF08454 | |
| Domain | RIH_dom | 1.52e-03 | 6 | 191 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.52e-03 | 6 | 191 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.52e-03 | 6 | 191 | 2 | IPR015925 | |
| Domain | - | 1.52e-03 | 6 | 191 | 2 | 1.25.10.30 | |
| Domain | FAT | 1.52e-03 | 6 | 191 | 2 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 1.52e-03 | 6 | 191 | 2 | IPR003151 | |
| Domain | RYDR_ITPR | 1.52e-03 | 6 | 191 | 2 | PF01365 | |
| Domain | LDrepeatLR_classA_rpt | 1.57e-03 | 49 | 191 | 4 | IPR002172 | |
| Domain | LDLa | 1.57e-03 | 49 | 191 | 4 | SM00192 | |
| Domain | LDLRA_2 | 1.57e-03 | 49 | 191 | 4 | PS50068 | |
| Domain | AAA | 1.96e-03 | 52 | 191 | 4 | PF00004 | |
| Pubmed | SMG1 HK2 NOL6 CLPX TUBGCP4 TUFM ITPR1 SH3BP4 AFG3L2 AP1M1 ANAPC5 RIC1 RC3H2 PKP4 CAMSAP3 BTAF1 FHIP2A MAP3K6 EIF2D ELMO2 CDK5RAP1 AP4B1 | 1.84e-11 | 650 | 194 | 22 | 38777146 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MYCBP2 SIPA1L3 ITGA3 RYR1 SH3BP4 HAUS4 TNRC18 PNPLA6 NCAPD2 RGL2 RIC1 SMG6 TFEB BTAF1 HUWE1 SCAP MROH1 GRTP1 MTOR NAPRT PLA2G4B CHD5 EHMT1 PDCD11 LRP5 PRKDC HTT | 1.35e-10 | 1105 | 194 | 27 | 35748872 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | HK2 MYCBP2 NOL6 CLPX TRIP12 TUFM ACSL1 PTPN14 PNPLA6 UBTF AFG3L2 NCAPD2 AP1M1 UTP20 CORO7 PKP4 LARS1 FARSB HUWE1 RFC1 RFC2 EIF2D PDCD11 MACF1 CCAR2 HADHA PRKDC LAS1L FSCN1 | 5.52e-10 | 1353 | 194 | 29 | 29467282 |
| Pubmed | HK2 MYCBP2 CENPE ITGA1 TUBGCP4 CD320 TTK CHMP2A TUFM ITPR1 ACSL1 PNPLA6 NCAPD2 AP1M1 CORO7 ATL2 FARSB PDCD2L HUWE1 PRDX6 MTOR MARCHF5 CHD5 PRKDC LAS1L ACAP2 | 2.17e-09 | 1168 | 194 | 26 | 19946888 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | NOL6 CLPX TRIP12 TUFM FDXR AP1M1 UTP20 DNAH5 LARS1 FARSB HUWE1 RFC2 MTOR EIF5 EHMT1 SMARCB1 PDCD11 HADHA PRKDC FSCN1 | 3.25e-09 | 704 | 194 | 20 | 29955894 |
| Pubmed | MYH2 NAPG AFG3L2 RMC1 LARS1 FARSB MON1B MAP3K6 TFCP2 MAPK14 MTOR EIF5 CCAR2 HADHA PRKDC MAST3 | 3.90e-09 | 437 | 194 | 16 | 20562859 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | CENPE TBC1D2 TRIP12 TUFM RYR1 R3HCC1L MYO3B UTP20 TNPO2 CAMSAP3 DDI2 PIWIL2 HUWE1 IVNS1ABP TAF6L FRY LOXHD1 HADHA PRKDC LONRF2 | 6.85e-09 | 736 | 194 | 20 | 29676528 |
| Pubmed | SMG1 MYH2 TBRG4 HK2 NOL6 NAPG CLPX TUBGCP4 TUFM ITPR1 UBTF AFG3L2 NCAPD2 TNPO2 LARS1 FARSB BTAF1 HUWE1 RFC1 RFC2 FHIP2A GFM2 MTOR PDCD11 CCAR2 HADHA PRKDC LAS1L | 9.42e-09 | 1440 | 194 | 28 | 30833792 | |
| Pubmed | TBRG4 TSPYL1 TUBGCP4 TUFM ACSL1 HAUS4 AFG3L2 NCAPD2 AP1M1 ANAPC5 TNPO2 RFC1 RFC2 ELMO2 EHMT1 HADHA LAS1L | 2.00e-08 | 560 | 194 | 17 | 35241646 | |
| Pubmed | ATAD5 ITGA3 TSPYL1 CLPX CHMP2A TUFM PTPN14 PNPLA6 BRDT ANKRD2 AFG3L2 ANAPC5 ARMC6 PKP4 CHD9 PDCD2L RFC2 TAF6L OSM CHD5 EHMT1 SMARCB1 MACF1 | 7.97e-08 | 1116 | 194 | 23 | 31753913 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TBRG4 HK2 NOL6 CLPX TUFM UBTF NCAPD2 AP1M1 UTP20 ATL2 DNAH5 LARS1 FARSB HUWE1 RFC1 RFC2 TFCP2 PRDX6 IVNS1ABP MTOR EIF5 EHMT1 PDCD11 CCAR2 HADHA PRKDC | 1.17e-07 | 1425 | 194 | 26 | 30948266 |
| Pubmed | SMG1 MYH2 SIPA1L3 NOL6 RGS11 ACTN3 CLPX TRIP12 TUFM TNRC18 NCAPD2 DLG3 COL20A1 CAMSAP3 GRIA2 STS CEP112 CHD5 NAA20 MTTP MACF1 MYH15 CCAR2 HADHA PRKDC PCK1 | 1.48e-07 | 1442 | 194 | 26 | 35575683 | |
| Pubmed | MYCBP2 NOL6 TRIP12 TUFM UBTF NCAPD2 UTP20 HUWE1 RFC1 MTOR PDCD11 MACF1 CCAR2 HADHA PRKDC LAS1L FSCN1 | 1.79e-07 | 653 | 194 | 17 | 22586326 | |
| Pubmed | MYCBP2 ITGA3 CLPX TRIP12 TTK AFG3L2 ARMC6 LARS1 FARSB PDCD2L RFC1 RFC2 IVNS1ABP EGFR NAPRT CEP112 EIF5 EHMT1 SMARCB1 PDCD11 MACF1 CCAR2 HADHA PRKDC | 2.92e-07 | 1297 | 194 | 24 | 33545068 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | TBRG4 HK2 TSPYL1 TRIP12 TUFM PNPLA6 NCAPD2 UTP20 CORO7 ANAPC5 LARS1 FARSB PDCD2L BTAF1 HUWE1 SCAP MTOR LRP6 HADHA PRKDC | 3.73e-07 | 942 | 194 | 20 | 31073040 |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | ATAD5 TSPYL1 TRIP12 ANAPC5 TNPO2 LARS1 CHD9 RFC1 RFC2 SMARCB1 PDCD11 HADHA PRKDC | 3.85e-07 | 394 | 194 | 13 | 27248496 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | HK2 NCAPD2 LARS1 FARSB NIBAN2 HUWE1 RFC2 PRDX6 EHMT1 CCAR2 PRKDC LAS1L | 4.18e-07 | 332 | 194 | 12 | 32786267 |
| Pubmed | NOL6 TRIP12 HAUS4 UBTF AFG3L2 NCAPD2 RC3H2 HUWE1 RFC1 RFC2 EHMT1 SMARCB1 CCAR2 FSCN1 | 4.53e-07 | 469 | 194 | 14 | 27634302 | |
| Pubmed | TSPYL1 TNRC18 NCAPD2 ANAPC5 SMG6 CHD9 TAF6L SMARCB1 MACF1 CCAR2 LAS1L | 6.08e-07 | 282 | 194 | 11 | 23667531 | |
| Pubmed | HK2 SIPA1L3 CLPX PTPN14 PNPLA6 AP1M1 RGL2 PKP4 FARSB EGFR SMARCB1 PDCD11 MACF1 HADHA LAS1L FSCN1 | 6.30e-07 | 634 | 194 | 16 | 34591612 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | SIPA1L3 NOL6 TRIP12 TUFM PTPN14 PNPLA6 UBTF AFG3L2 AP1M1 UTP20 PKP4 LARS1 FARSB RFC1 RFC2 EGFR CHD5 EIF5 PDCD11 HADHA PRKDC LAS1L FSCN1 | 6.40e-07 | 1257 | 194 | 23 | 36526897 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | HK2 MYCBP2 TSPYL1 CLPX TUFM ACSL1 AFG3L2 TSEN34 AP1M1 ARMC6 LARS1 FARSB BTAF1 HUWE1 RFC1 RFC2 PRDX6 TAF6L SMARCB1 CCAR2 HADHA PRKDC LAS1L | 6.40e-07 | 1257 | 194 | 23 | 37317656 |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | SMG1 TBRG4 SIPA1L3 TSPYL1 CLPX PNPLA6 UBTF FDXR PPFIBP2 PKP4 PDCD2L BTAF1 NIBAN2 EGFR CDK5RAP1 MACF1 ACAP2 | 6.82e-07 | 719 | 194 | 17 | 35337019 |
| Pubmed | MYCBP2 ATAD5 MTMR1 CLPX TTK ITPR1 SH3BP4 PTPN14 R3HCC1L PNPLA6 UBTF AFG3L2 PKP4 NIBAN2 TFCP2 WDR19 EGFR EHMT1 CDK5RAP1 PDCD11 MACF1 HADHA LAS1L FSCN1 MAST3 | 9.44e-07 | 1487 | 194 | 25 | 33957083 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MYCBP2 SIPA1L3 SH3BP4 TNRC18 PNPLA6 HSD11B2 RIC1 SMG6 PPFIBP2 CAMSAP3 WASHC3 TPGS1 CHD9 BTAF1 HUWE1 PRDX6 KLK4 GRTP1 EGFR EHMT1 CDK5RAP1 MAST1 LRP5 MACF1 HTT | 9.67e-07 | 1489 | 194 | 25 | 28611215 |
| Pubmed | ATAD5 SIPA1L3 NOL6 TSPYL1 TUFM PNPLA6 UTS2 AFG3L2 NCAPD2 UTP20 DLG3 ANAPC5 SMG6 PKP4 CAMSAP3 FARSB RFC2 TAF6L MICALL2 EIF5 EHMT1 PDCD11 MACF1 LAS1L THAP12 | 1.07e-06 | 1497 | 194 | 25 | 31527615 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | GPR155 NAPG ITGA1 ITGA3 HDHD2 ACE CHMP2A RYR1 SH3BP4 C16orf89 AP1M1 ALK VWF UBL3 NIBAN2 HUWE1 PRDX6 ARSL NAPRT PCK1 | 1.20e-06 | 1016 | 194 | 20 | 19056867 |
| Pubmed | Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins. | 1.34e-06 | 190 | 194 | 9 | 15161933 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | MYCBP2 CENPE ATAD5 NOL6 TSPYL1 TRIP12 UBTF UTP20 LARS1 FARSB RFC1 RFC2 PDCD11 MACF1 CCAR2 PRKDC LAS1L | 1.43e-06 | 759 | 194 | 17 | 35915203 |
| Pubmed | 1.80e-06 | 197 | 194 | 9 | 36604605 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | MYCBP2 CEP85L SIPA1L3 TRIP12 TTK SH3BP4 PTPN14 AP1M1 RGL2 TFEB CAMSAP3 MAP3K6 IVNS1ABP MTOR ELMO2 CEP112 EIF5 MACF1 | 1.83e-06 | 861 | 194 | 18 | 36931259 |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | ATAD5 NOL6 TRIP12 BRDT UBTF AURKAIP1 ANAPC5 CENPT TNPO2 CHD9 RFC1 RFC2 SMARCB1 LAS1L | 2.04e-06 | 533 | 194 | 14 | 30554943 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 2.22e-06 | 202 | 194 | 9 | 33005030 | |
| Pubmed | 3.05e-06 | 210 | 194 | 9 | 16565220 | ||
| Pubmed | TSPYL1 TUBGCP4 TUFM NCAPD2 ARMC6 CAMSAP3 BTAF1 HUWE1 PRDX6 IVNS1ABP MTOR ELMO2 EIF5 PRKDC ACAP2 | 4.82e-06 | 657 | 194 | 15 | 36180527 | |
| Pubmed | MYCBP2 CENPE CHMP2A ITPR1 TNRC18 R3HCC1L NCAPD2 TSEN34 DLG3 SPSB4 NAALAD2 DDI2 NIBAN2 ITGB3BP TGIF1 SCAP MROH1 ARSL NAPRT HADHA ACOXL | 4.91e-06 | 1215 | 194 | 21 | 15146197 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | TBRG4 NOL6 CLPX TRIP12 TTK TUFM AFG3L2 AP1M1 ARMC6 LARS1 FARSB HUWE1 RFC1 RFC2 PRDX6 SMARCB1 PDCD11 CCAR2 HADHA PRKDC LAS1L FSCN1 | 5.01e-06 | 1318 | 194 | 22 | 30463901 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | MYCBP2 NOL6 TRIP12 TUFM UBTF AFG3L2 UTP20 LARS1 BTAF1 HUWE1 RFC2 PRDX6 TAF6L PDCD11 MACF1 CCAR2 HADHA PRKDC LAS1L | 5.26e-06 | 1024 | 194 | 19 | 24711643 |
| Pubmed | 5.27e-06 | 120 | 194 | 7 | 27320910 | ||
| Pubmed | 5.34e-06 | 225 | 194 | 9 | 12168954 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | TUBGCP4 TRUB1 TRIP12 TTK NCAPD2 RBM45 BTAF1 NIBAN2 HUWE1 RFC2 EIF2D MACF1 PRKDC LAS1L | 5.59e-06 | 582 | 194 | 14 | 20467437 |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | NOL6 TUFM PDCD2L HUWE1 RFC1 TFCP2 PRDX6 IVNS1ABP MAPK14 EHMT1 PDCD11 CCAR2 PRKDC ACAP2 | 5.70e-06 | 583 | 194 | 14 | 29844126 |
| Pubmed | 5.88e-06 | 7 | 194 | 3 | 29431745 | ||
| Pubmed | Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations. | 7.58e-06 | 235 | 194 | 9 | 28378594 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | MYCBP2 TBC1D2 TRIP12 MYO3A PNPLA6 UTP20 ANAPC5 CAMSAP3 BTAF1 NIBAN2 HUWE1 RFC1 EIF2D EGFR CCAR2 PRKDC | 8.05e-06 | 774 | 194 | 16 | 15302935 |
| Pubmed | 9.38e-06 | 8 | 194 | 3 | 29246441 | ||
| Pubmed | 9.38e-06 | 8 | 194 | 3 | 20810650 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | TBRG4 HK2 MYCBP2 CENPE CLPX TTK TUFM ITPR1 PTPN14 AFG3L2 TRMT5 SMG6 TPGS1 HUWE1 TFCP2 GFM2 MARCHF5 CDK5RAP1 PDCD11 CCAR2 HADHA LAS1L MMUT | 1.14e-05 | 1496 | 194 | 23 | 32877691 |
| Pubmed | MTMR1 TTK AFG3L2 NCAPD2 RAB12 LARS1 FARSB NIBAN2 PRDX6 EGFR EIF5 LRP6 MACF1 HADHA PRKDC | 1.17e-05 | 708 | 194 | 15 | 39231216 | |
| Pubmed | MYCBP2 CCDC174 ACSL1 TNRC18 UBTF RARA TNPO2 LARS1 FARSB CHD9 RFC1 RFC2 TGIF1 EIF5 EHMT1 SMARCB1 CCAR2 HADHA PRKDC | 1.49e-05 | 1103 | 194 | 19 | 34189442 | |
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | SMG1 TDRD9 MTMR1 TUBGCP4 HAUS4 PNPLA6 TPGS1 HUWE1 RFC2 MMRN1 FRY HADHA PRKDC LAS1L | 1.59e-05 | 639 | 194 | 14 | 23443559 |
| Pubmed | SIPA1L3 MTMR1 ACTN3 HDHD2 TUFM CDKL5 PNPLA6 AFG3L2 DLG3 CORO7 VWF PKP4 CAMSAP3 LARS1 FARSB GRIA2 TPGS1 PRDX6 MAST1 MACF1 HADHA FSCN1 | 1.79e-05 | 1431 | 194 | 22 | 37142655 | |
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | TBRG4 CEP85L AMACR TTK ACSL1 TSEN34 AP1M1 ANAPC5 CENPT PKP4 LARS1 CHD9 RFC2 PRDX6 NAPRT EIF5 ACAP2 | 1.90e-05 | 925 | 194 | 17 | 28986522 |
| Pubmed | Tel2 regulates the stability of PI3K-related protein kinases. | 1.99e-05 | 10 | 194 | 3 | 18160036 | |
| Pubmed | SHLD2/FAM35A co-operates with REV7 to coordinate DNA double-strand break repair pathway choice. | 2.26e-05 | 150 | 194 | 7 | 30154076 | |
| Pubmed | Mitochondrial protein interactome elucidated by chemical cross-linking mass spectrometry. | 2.53e-05 | 343 | 194 | 10 | 28130547 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | CENPE TRIP12 UBTF AFG3L2 NCAPD2 TSEN34 RIC1 CAMSAP3 CHD9 LOXHD1 SMARCB1 ANO3 | 2.55e-05 | 497 | 194 | 12 | 36774506 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | MYCBP2 MTMR1 TUFM NCAPD2 TNPO2 CAMSAP3 LARS1 FARSB HUWE1 RFC1 RFC2 PRDX6 IVNS1ABP EIF5 MACF1 CCAR2 HADHA PRKDC FSCN1 | 2.61e-05 | 1149 | 194 | 19 | 35446349 |
| Pubmed | MYCBP2 ATAD5 SIPA1L3 MTMR1 CLPX ITPR1 PTPN14 UBTF AFG3L2 PKP4 CAMSAP3 NIBAN2 HUWE1 MAPK14 EGFR LRP6 CCAR2 HADHA | 2.65e-05 | 1049 | 194 | 18 | 27880917 | |
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 2.69e-05 | 104 | 194 | 6 | 31240132 | |
| Pubmed | Tti1 and Tel2 are critical factors in mammalian target of rapamycin complex assembly. | 2.73e-05 | 11 | 194 | 3 | 20427287 | |
| Pubmed | SIPA1L3 NOL6 ACTN3 CLPX TRUB1 TRIP12 CHMP2A TUFM AURKAIP1 ALK RC3H2 RBM45 FARSB RFC1 RFC2 TFCP2 PRDX6 SMARCB1 PDCD11 HADHA LAS1L | 2.97e-05 | 1371 | 194 | 21 | 36244648 | |
| Pubmed | Lacrimal gland budding requires PI3K-dependent suppression of EGF signaling. | 2.99e-05 | 32 | 194 | 4 | 34193412 | |
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 24885886 | ||
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 19175495 | ||
| Pubmed | The antidepressant tianeptine reverts synaptic AMPA receptor defects caused by deficiency of CDKL5. | 3.10e-05 | 2 | 194 | 2 | 29618004 | |
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 28177711 | ||
| Pubmed | LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way. | 3.10e-05 | 2 | 194 | 2 | 15084453 | |
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 38139347 | ||
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 25577516 | ||
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 31201299 | ||
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 32017279 | ||
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 11919185 | ||
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 33164872 | ||
| Pubmed | Non-small cell lung cancer in the very young: Higher EGFR/ALK mutation proportion than the elder. | 3.10e-05 | 2 | 194 | 2 | 32221155 | |
| Pubmed | [Advances in Double Mutations of EGFR and ALK Gene in Non-small Cell Lung Cancer]. | 3.10e-05 | 2 | 194 | 2 | 30201068 | |
| Pubmed | Mutant huntingtin regulates EGF receptor fate in non-neuronal cells lacking wild-type protein. | 3.10e-05 | 2 | 194 | 2 | 22974559 | |
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 27268034 | ||
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 29199696 | ||
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 33862316 | ||
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 20010124 | ||
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 15657358 | ||
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 27582493 | ||
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 25783012 | ||
| Pubmed | Gene targeting approaches in mice: assessing the roles of LRP5 and LRP6 in osteoblasts. | 3.10e-05 | 2 | 194 | 2 | 19147944 | |
| Pubmed | Decreased BMD and limb deformities in mice carrying mutations in both Lrp5 and Lrp6. | 3.10e-05 | 2 | 194 | 2 | 15537447 | |
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 24313907 | ||
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 24114905 | ||
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 22569898 | ||
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 26555338 | ||
| Pubmed | The Wnt co-receptor Lrp6 is required for normal mouse mammary gland development. | 3.10e-05 | 2 | 194 | 2 | 19503830 | |
| Pubmed | Genetic ACE I/D and ACTN3 R577X polymorphisms and adolescent idiopathic scoliosis. | 3.10e-05 | 2 | 194 | 2 | 27819725 | |
| Pubmed | Co-targeting EGFR and mTOR with gefitinib and everolimus in triple-negative breast cancer cells. | 3.10e-05 | 2 | 194 | 2 | 32286420 | |
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 29582563 | ||
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 36360246 | ||
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 28557060 | ||
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 23384112 | ||
| Pubmed | Higher frequency of the ACTN3 R allele + ACE DD genotype in Japanese elite wrestlers. | 3.10e-05 | 2 | 194 | 2 | 22996021 | |
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 28425175 | ||
| Pubmed | Mouse class III myosins: kinase activity and phosphorylation sites. | 3.10e-05 | 2 | 194 | 2 | 21895655 | |
| Interaction | NPTN interactions | SMG1 TBRG4 TSPYL1 TTK UTP20 RTL8C ARMC6 TNPO2 BTAF1 HUWE1 GFM2 MROH1 MTOR HTT | 4.47e-07 | 278 | 191 | 14 | int:NPTN |
| Interaction | GPR17 interactions | TBRG4 TUBGCP4 CD320 TTK NCAPD2 UTP20 ATL2 ARMC6 TNPO2 BTAF1 FHIP2A MTOR PRKDC HTT | 5.54e-07 | 283 | 191 | 14 | int:GPR17 |
| Interaction | CD80 interactions | 8.25e-07 | 79 | 191 | 8 | int:CD80 | |
| Interaction | MAS1 interactions | 1.59e-06 | 86 | 191 | 8 | int:MAS1 | |
| Interaction | PARP1 interactions | HK2 MYCBP2 ATAD5 RC3H1 NOL6 TRIP12 SH3BP4 UBTF NCAPD2 UTP20 RARA RBM45 BTAF1 HUWE1 RFC1 RFC2 TFCP2 PRDX6 IVNS1ABP TAF6L EGFR MTOR EHMT1 SMARCB1 PDCD11 CCAR2 HADHA PRKDC LAS1L FSCN1 MAST3 | 2.35e-06 | 1316 | 191 | 31 | int:PARP1 |
| Interaction | NPY2R interactions | 2.99e-06 | 66 | 191 | 7 | int:NPY2R | |
| Interaction | TOP3B interactions | MYCBP2 SIPA1L3 ITGA3 CLPX TUFM RYR1 SH3BP4 HAUS4 TNRC18 PNPLA6 NCAPD2 RGL2 RIC1 SMG6 TFEB RC3H2 LARS1 BTAF1 HUWE1 TFCP2 SCAP MROH1 GRTP1 MTOR NAPRT PLA2G4B CHD5 EHMT1 PDCD11 LRP5 HADHA PRKDC HTT | 3.00e-06 | 1470 | 191 | 33 | int:TOP3B |
| Interaction | OPALIN interactions | TBRG4 TUBGCP4 MYO3B UTP20 TNPO2 BTAF1 NIBAN2 TAF6L MROH1 MTOR PRKDC | 5.19e-06 | 209 | 191 | 11 | int:OPALIN |
| Interaction | RPS16 interactions | RC3H1 WSB2 TSPYL1 TUBGCP4 TUFM RC3H2 RARA RBM45 LARS1 HUWE1 RFC1 RFC2 TFCP2 EIF2D MICALL2 EGFR EIF5 PDCD11 LAS1L THAP12 HTT | 5.54e-06 | 724 | 191 | 21 | int:RPS16 |
| Interaction | DKK1 interactions | 1.19e-05 | 32 | 191 | 5 | int:DKK1 | |
| Interaction | YWHAQ interactions | MYH2 MYCBP2 CEP85L RC3H1 SIPA1L3 TRIP12 SH3BP4 PTPN14 RGL2 TFEB PPFIBP2 CAMSAP3 RFC1 TFCP2 IVNS1ABP EGFR MTOR CEP112 EIF5 MACF1 CCAR2 HADHA PRKDC FSCN1 PCK1 HTT | 2.11e-05 | 1118 | 191 | 26 | int:YWHAQ |
| Interaction | H2AC4 interactions | ATAD5 TSPYL1 TRIP12 DNAH5 ANAPC5 RBM45 TNPO2 LARS1 CHD9 RFC1 RFC2 TFCP2 MICALL2 SMARCB1 PDCD11 PRKDC | 2.74e-05 | 506 | 191 | 16 | int:H2AC4 |
| Interaction | MRPL43 interactions | 2.87e-05 | 165 | 191 | 9 | int:MRPL43 | |
| Interaction | YWHAB interactions | MYCBP2 CENPE CEP85L RC3H1 SIPA1L3 TRIP12 SH3BP4 PTPN14 ATL2 RGL2 TFEB RC3H2 RARA GNPTAB CAMSAP3 TFCP2 IVNS1ABP EGFR MTOR CEP112 MAST1 MACF1 MAST3 HTT | 3.41e-05 | 1014 | 191 | 24 | int:YWHAB |
| Interaction | CD83 interactions | 3.80e-05 | 66 | 191 | 6 | int:CD83 | |
| Interaction | RNF123 interactions | CENPE TBC1D2 TRIP12 TUFM RYR1 R3HCC1L MYO3B UTP20 TNPO2 CAMSAP3 DDI2 PIWIL2 HUWE1 MAP3K6 IVNS1ABP TAF6L FRY LOXHD1 HADHA PRKDC LONRF2 | 3.81e-05 | 824 | 191 | 21 | int:RNF123 |
| Interaction | HSPD1 interactions | TBRG4 AMACR RC3H1 ITGA1 ITGA3 CLPX TUFM PTPN14 AFG3L2 NCAPD2 AURKAIP1 TRMT5 ALK RBM45 LARS1 DDI2 HUWE1 TFCP2 MAPK14 EGFR CCAR2 HADHA PCK1 HTT | 3.86e-05 | 1022 | 191 | 24 | int:HSPD1 |
| Interaction | AMACR interactions | 4.14e-05 | 67 | 191 | 6 | int:AMACR | |
| Interaction | YWHAE interactions | MYCBP2 CENPE CEP85L RC3H1 SIPA1L3 TRIP12 SH3BP4 PTPN14 RGL2 TFEB RC3H2 PPFIBP2 CAMSAP3 LARS1 HUWE1 PRDX6 IVNS1ABP MAPK14 MTOR CEP112 EIF5 MAST1 MACF1 CCAR2 ACAP2 MAST3 HTT | 5.65e-05 | 1256 | 191 | 27 | int:YWHAE |
| Interaction | HSP90AA1 interactions | SMG1 HK2 WSB2 RGS11 TTK TUFM MYO3B AFG3L2 TSSK3 ALK RC3H2 LARS1 DDI2 PIWIL2 HUWE1 MAP3K6 TFCP2 RBCK1 MAPK14 EGFR MTOR MARCHF5 MAST1 CCAR2 HADHA PRKDC HTT | 6.20e-05 | 1263 | 191 | 27 | int:HSP90AA1 |
| Interaction | HNRNPCL2 interactions | MYCBP2 ATAD5 TRIP12 CORO7 RBM45 CAMSAP3 RFC1 RFC2 MAP3K6 MAST1 PDCD11 | 6.40e-05 | 274 | 191 | 11 | int:HNRNPCL2 |
| Interaction | GABRA2 interactions | 6.75e-05 | 9 | 191 | 3 | int:GABRA2 | |
| Interaction | KCNA3 interactions | MTMR1 TTK RYR1 UBTF AFG3L2 NCAPD2 DNAH5 RAB12 LARS1 FARSB CHD9 NIBAN2 PRDX6 TAF6L EGFR CEP112 EIF5 LRP6 MACF1 HADHA PRKDC | 8.41e-05 | 871 | 191 | 21 | int:KCNA3 |
| Interaction | NR1D1 interactions | 8.46e-05 | 25 | 191 | 4 | int:NR1D1 | |
| Interaction | C9orf78 interactions | TBRG4 TSPYL1 TUBGCP4 TUFM ACSL1 HAUS4 AFG3L2 NCAPD2 AP1M1 ANAPC5 TNPO2 RFC1 RFC2 ELMO2 EHMT1 HADHA LAS1L | 9.02e-05 | 620 | 191 | 17 | int:C9orf78 |
| Interaction | C3orf18 interactions | 1.14e-04 | 115 | 191 | 7 | int:C3orf18 | |
| Interaction | DDX4 interactions | 1.16e-04 | 27 | 191 | 4 | int:DDX4 | |
| Interaction | HSP90AB1 interactions | MYCBP2 TUFM CDKL5 TNRC18 MYO3B AFG3L2 RC3H2 RBM45 LARS1 DDI2 HUWE1 TFCP2 IVNS1ABP MAPK14 EGFR MTOR MARCHF5 MAST1 CCAR2 HADHA PRKDC HTT | 1.18e-04 | 960 | 191 | 22 | int:HSP90AB1 |
| Interaction | YWHAZ interactions | MYCBP2 CEP85L SIPA1L3 MTMR1 TRIP12 TUFM ITPR1 SH3BP4 MYO3A PTPN14 ATL2 TFEB RARA PPFIBP2 CAMSAP3 HUWE1 IVNS1ABP EGFR MTOR CEP112 EIF5 SMARCB1 MAST1 MACF1 CCAR2 MAST3 HTT | 1.28e-04 | 1319 | 191 | 27 | int:YWHAZ |
| Interaction | NDUFA9 interactions | TBRG4 HK2 TUFM AFG3L2 AURKAIP1 RC3H2 GFM2 EGFR MTOR HADHA ACAP2 HTT | 1.31e-04 | 349 | 191 | 12 | int:NDUFA9 |
| Interaction | TRIM28 interactions | MYCBP2 RC3H1 NOL6 CLPX TRIP12 TUFM FDXR AP1M1 UTP20 RMC1 DNAH5 RC3H2 RBM45 LARS1 FARSB GRIA2 HUWE1 RFC2 EGFR MTOR EIF5 EHMT1 SMARCB1 PDCD11 CCAR2 HADHA PRKDC FSCN1 MAST3 | 1.40e-04 | 1474 | 191 | 29 | int:TRIM28 |
| Interaction | TNFSF13B interactions | 1.41e-04 | 119 | 191 | 7 | int:TNFSF13B | |
| Interaction | LRRC31 interactions | 1.53e-04 | 205 | 191 | 9 | int:LRRC31 | |
| Interaction | APEX1 interactions | TBRG4 CEP85L ATAD5 AMACR TRIP12 TTK ACSL1 UBTF TSEN34 AP1M1 ANAPC5 CENPT PKP4 LARS1 CHD9 RFC1 RFC2 PRDX6 EGFR NAPRT EIF5 EHMT1 PDCD11 PRKDC LAS1L ACAP2 | 1.74e-04 | 1271 | 191 | 26 | int:APEX1 |
| Interaction | CCDC8 interactions | MYCBP2 TRIP12 TUFM AFG3L2 UTP20 MROH2A LARS1 BTAF1 HUWE1 RFC2 TAF6L MAPK14 PDCD11 MACF1 CCAR2 HADHA PRKDC | 1.77e-04 | 656 | 191 | 17 | int:CCDC8 |
| Interaction | RPS3 interactions | RC3H1 NOL6 WSB2 TUBGCP4 TUFM RC3H2 RARA RBM45 LARS1 HUWE1 TFCP2 MICALL2 EGFR EIF5 PDCD11 THAP12 PCK1 HTT | 1.81e-04 | 721 | 191 | 18 | int:RPS3 |
| Interaction | SOX2 interactions | ATAD5 SIPA1L3 TSPYL1 TRIP12 RYR1 TNRC18 UBTF NCAPD2 ANAPC5 SMG6 TFEB PPFIBP2 PKP4 GNPTAB LARS1 CHD9 RFC1 RFC2 PRDX6 TAF6L EGFR EHMT1 SMARCB1 PDCD11 MACF1 CCAR2 HADHA LAS1L | 1.82e-04 | 1422 | 191 | 28 | int:SOX2 |
| Interaction | GATB interactions | 1.82e-04 | 124 | 191 | 7 | int:GATB | |
| Interaction | H2BC4 interactions | 1.89e-04 | 259 | 191 | 10 | int:H2BC4 | |
| Interaction | AFG3L2 interactions | TBRG4 RC3H1 WSB2 TUFM AFG3L2 AURKAIP1 RC3H2 RBM45 MAP3K6 GFM2 EGFR MACF1 | 1.98e-04 | 365 | 191 | 12 | int:AFG3L2 |
| Interaction | USP9X interactions | RC3H1 MTMR1 TTK PTPN14 MYO3B RMC1 RBM45 HUWE1 EGFR MTOR MAST1 HADHA HTT | 2.03e-04 | 422 | 191 | 13 | int:USP9X |
| Interaction | DDA1 interactions | WSB2 UBTF SPSB4 ANAPC5 TFEB LARS1 FARSB FRY EGFR EIF5 HADHA PRKDC | 2.13e-04 | 368 | 191 | 12 | int:DDA1 |
| Interaction | MAPK1 interactions | CENPE TUBGCP4 LRRC4 UBTF ALK RARA GNPTAB HUWE1 TFCP2 PRDX6 TGIF1 MAPK14 EGFR MTOR HTT | 2.18e-04 | 543 | 191 | 15 | int:MAPK1 |
| Interaction | TUBB interactions | RC3H1 TUBGCP4 TTK ARMC6 RC3H2 RBM45 TNPO2 LARS1 HUWE1 TFCP2 MICALL2 EGFR MTOR EIF5 CDK5RAP1 HADHA LAS1L HTT | 2.28e-04 | 735 | 191 | 18 | int:TUBB |
| Interaction | MDK interactions | 2.29e-04 | 91 | 191 | 6 | int:MDK | |
| Interaction | MRPS34 interactions | TBRG4 RC3H1 TSPYL1 TUFM MYO3B AURKAIP1 HUWE1 GFM2 MAST1 FSCN1 THAP12 | 2.30e-04 | 317 | 191 | 11 | int:MRPS34 |
| Interaction | LANCL2 interactions | 2.58e-04 | 93 | 191 | 6 | int:LANCL2 | |
| Interaction | MRPS14 interactions | 2.59e-04 | 220 | 191 | 9 | int:MRPS14 | |
| Interaction | CENPA interactions | ATAD5 TRIP12 UBTF UTP20 CENPT TPGS1 RFC1 RFC2 EHMT1 PDCD11 PRKDC LAS1L | 2.66e-04 | 377 | 191 | 12 | int:CENPA |
| Interaction | IBA57 interactions | 2.73e-04 | 94 | 191 | 6 | int:IBA57 | |
| Interaction | ATG101 interactions | 2.73e-04 | 94 | 191 | 6 | int:ATG101 | |
| Interaction | BRD3 interactions | ATAD5 NOL6 TSPYL1 TRIP12 UBTF ANKRD2 ANAPC5 CENPT CHD9 RFC1 RFC2 EGFR EHMT1 SMARCB1 | 2.73e-04 | 494 | 191 | 14 | int:BRD3 |
| Interaction | RAC3 interactions | MTMR1 ITGA1 ITGA3 CD320 ITPR1 SH3BP4 UBTF AFG3L2 UTP20 DLG3 PKP4 NIBAN2 EGFR LRP6 LRP5 MACF1 | 2.83e-04 | 619 | 191 | 16 | int:RAC3 |
| Interaction | MRPS6 interactions | 2.93e-04 | 177 | 191 | 8 | int:MRPS6 | |
| Interaction | GPHN interactions | 2.93e-04 | 134 | 191 | 7 | int:GPHN | |
| Interaction | KIF23 interactions | NOL6 CLPX TUFM HEPACAM TNRC18 UTS2 UBTF TNPO2 LARS1 CHD9 HUWE1 RFC1 PRDX6 FRY EGFR PDCD11 MACF1 HADHA PRKDC LONRF2 THAP12 HTT | 3.21e-04 | 1031 | 191 | 22 | int:KIF23 |
| Interaction | YWHAG interactions | MYCBP2 CEP85L RC3H1 SIPA1L3 TRIP12 TTK SH3BP4 PTPN14 AP1M1 RGL2 TFEB RC3H2 RARA PPFIBP2 CAMSAP3 HUWE1 MAP3K6 MTOR ELMO2 CEP112 EIF5 MACF1 PRKDC MAST3 HTT | 3.22e-04 | 1248 | 191 | 25 | int:YWHAG |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.05e-05 | 181 | 115 | 8 | 694 | |
| GeneFamily | AAA ATPases | 2.15e-05 | 53 | 115 | 5 | 413 | |
| GeneFamily | Myosins, class III|Deafness associated genes | 4.01e-05 | 2 | 115 | 2 | 1099 | |
| Coexpression | GSE22611_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_UP | CENPE ITPR1 UTS2 UTP20 RTL8C AMT MARCHF5 EIF5 CDK5RAP1 HADHA | 2.17e-06 | 197 | 193 | 10 | M8166 |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN | NOL6 TBC1D2 PNPLA6 LRP5L RAB12 AMT RARA FARSB NIBAN2 RBCK1 TAF6L OSM SCAP ELMO2 PLA2G4B CDK5RAP1 AP4B1 | 5.07e-06 | 634 | 193 | 17 | M40866 |
| Coexpression | GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_DN | 1.85e-05 | 200 | 193 | 9 | M7174 | |
| Coexpression | MOOTHA_HUMAN_MITODB_6_2002 | AMACR CLPX TUFM ACSL1 R3HCC1L FDXR AFG3L2 AMT IVNS1ABP MTOR MAST1 HADHA MMUT | 2.08e-05 | 432 | 193 | 13 | M9433 |
| Coexpression | GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN | 3.34e-05 | 166 | 193 | 8 | M6826 | |
| ToppCell | IIH-CD8-naive_CD4|IIH / Condition, Cell_class and T cell subcluster | 7.21e-08 | 173 | 194 | 9 | 4f2843371d18af766c1892529ce286f56c956fde | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Neuron|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.04e-06 | 175 | 194 | 8 | 2812ac2ef41d245db544697fb6da1883361c96e8 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-06 | 175 | 194 | 8 | bb058e714d21a0ec8532eaf3c7dd2faf78016bc0 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.78e-06 | 188 | 194 | 8 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.19e-05 | 175 | 194 | 7 | 9142ed8ca2f1c0c518deb21988221406f62fe38c | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-05 | 176 | 194 | 7 | 6b4afd2c9268172063fe5832896bea15e862579e | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 1.24e-05 | 176 | 194 | 7 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 1.28e-05 | 177 | 194 | 7 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-05 | 181 | 194 | 7 | cef034030e6b029a49ae56be37ea1fac1a5c350e | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.54e-05 | 182 | 194 | 7 | d486b0213bd3cf20965cb4e38e95981c4aaff259 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-05 | 184 | 194 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-05 | 184 | 194 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-05 | 184 | 194 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.83e-05 | 187 | 194 | 7 | 3699d5e71d779da922920aa3160895db187bf81b | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.83e-05 | 187 | 194 | 7 | 033ba52c0c2f9978784947098fa697368ae44834 | |
| Drug | 0317956-0000 [391210-11-0]; Down 200; 1uM; PC3; HT_HG-U133A | NOL6 MTMR1 ITPR1 R3HCC1L TFEB HUWE1 TAF6L MAPK14 EGFR FSCN1 GABRA2 | 7.88e-07 | 192 | 193 | 11 | 4334_DN |
| Drug | Dantrolene sodium salt [14663-23-1]; Down 200; 11.8uM; PC3; HT_HG-U133A | MTMR1 ITPR1 PTPN14 R3HCC1L TFEB HUWE1 MAPK14 EGFR EHMT1 FSCN1 GABRA2 | 8.29e-07 | 193 | 193 | 11 | 4343_DN |
| Drug | cilengitide | 1.55e-06 | 24 | 193 | 5 | CID000176873 | |
| Drug | fluphenazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 7.41e-06 | 197 | 193 | 10 | 1075_DN | |
| Disease | Ovarian Serous Adenocarcinoma | 1.23e-05 | 23 | 186 | 4 | C1335177 | |
| Disease | osteoporosis-pseudoglioma syndrome (implicated_via_orthology) | 3.95e-05 | 2 | 186 | 2 | DOID:0060849 (implicated_via_orthology) | |
| Disease | autosomal dominant polycystic kidney disease (implicated_via_orthology) | 8.52e-05 | 14 | 186 | 3 | DOID:898 (implicated_via_orthology) | |
| Disease | autosomal dominant polycystic kidney disease (is_implicated_in) | 2.35e-04 | 4 | 186 | 2 | DOID:898 (is_implicated_in) | |
| Disease | endomyocardial fibrosis (biomarker_via_orthology) | 2.35e-04 | 4 | 186 | 2 | DOID:12932 (biomarker_via_orthology) | |
| Disease | cancer (implicated_via_orthology) | 3.17e-04 | 268 | 186 | 8 | DOID:162 (implicated_via_orthology) | |
| Disease | diabetic retinopathy (is_marker_for) | 3.78e-04 | 54 | 186 | 4 | DOID:8947 (is_marker_for) | |
| Disease | Metastatic melanoma | 3.78e-04 | 54 | 186 | 4 | C0278883 | |
| Disease | focal segmental glomerulosclerosis 1 (implicated_via_orthology) | 3.90e-04 | 5 | 186 | 2 | DOID:0111128 (implicated_via_orthology) | |
| Disease | Etat Marbre | 3.98e-04 | 23 | 186 | 3 | C0266487 | |
| Disease | Intellectual Disability | 5.77e-04 | 447 | 186 | 10 | C3714756 | |
| Disease | amphetamine abuse (implicated_via_orthology) | 5.83e-04 | 6 | 186 | 2 | DOID:670 (implicated_via_orthology) | |
| Disease | nonsyndromic deafness (implicated_via_orthology) | 5.83e-04 | 6 | 186 | 2 | DOID:0050563 (implicated_via_orthology) | |
| Disease | tendinitis (biomarker_via_orthology) | 5.83e-04 | 6 | 186 | 2 | DOID:971 (biomarker_via_orthology) | |
| Disease | Hereditary, Type VII, Motor and Sensory Neuropathy | 5.83e-04 | 6 | 186 | 2 | C0019816 | |
| Disease | Hereditary Motor and Sensory Neuropathies | 5.83e-04 | 6 | 186 | 2 | C0027888 | |
| Disease | Movement Disorders | 7.98e-04 | 29 | 186 | 3 | C0026650 | |
| Disease | lysosomal protective protein measurement | 8.13e-04 | 7 | 186 | 2 | EFO_0008215 | |
| Disease | Dejerine-Sottas Disease (disorder) | 8.13e-04 | 7 | 186 | 2 | C0011195 | |
| Disease | polycystic liver disease (implicated_via_orthology) | 8.13e-04 | 7 | 186 | 2 | DOID:0050770 (implicated_via_orthology) | |
| Disease | osteonecrosis (biomarker_via_orthology) | 8.13e-04 | 7 | 186 | 2 | DOID:10159 (biomarker_via_orthology) | |
| Disease | exudative vitreoretinopathy (implicated_via_orthology) | 1.08e-03 | 8 | 186 | 2 | DOID:0050535 (implicated_via_orthology) | |
| Disease | cathepsin Z measurement | 1.08e-03 | 8 | 186 | 2 | EFO_0008074 | |
| Disease | N-acylethanolamine-hydrolyzing acid amidase measurement | 1.38e-03 | 9 | 186 | 2 | EFO_0008240 | |
| Disease | Alcoholic Intoxication, Chronic | 1.62e-03 | 268 | 186 | 7 | C0001973 | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 1.72e-03 | 10 | 186 | 2 | DOID:0111269 (implicated_via_orthology) | |
| Disease | Kunitz-type protease inhibitor 2 measurement | 1.72e-03 | 10 | 186 | 2 | EFO_0008200 | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 1.72e-03 | 10 | 186 | 2 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 1.72e-03 | 10 | 186 | 2 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 1.72e-03 | 10 | 186 | 2 | DOID:0110454 (implicated_via_orthology) | |
| Disease | familial hypercholesterolemia (is_implicated_in) | 1.72e-03 | 10 | 186 | 2 | DOID:13810 (is_implicated_in) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 1.72e-03 | 10 | 186 | 2 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 1.72e-03 | 10 | 186 | 2 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 1.72e-03 | 10 | 186 | 2 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 1.72e-03 | 10 | 186 | 2 | DOID:0080326 (implicated_via_orthology) | |
| Disease | Obesity | 1.97e-03 | 205 | 186 | 6 | C0028754 | |
| Disease | Inherited neuropathies | 2.05e-03 | 40 | 186 | 3 | C0598589 | |
| Disease | response to antihypertensive drug | 2.20e-03 | 41 | 186 | 3 | EFO_0005405 | |
| Disease | left ventricular structural measurement | 2.36e-03 | 88 | 186 | 4 | EFO_0008205 | |
| Disease | obesity (biomarker_via_orthology) | 2.45e-03 | 147 | 186 | 5 | DOID:9970 (biomarker_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 2.50e-03 | 12 | 186 | 2 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 2.50e-03 | 12 | 186 | 2 | DOID:2106 (implicated_via_orthology) | |
| Disease | hereditary spastic paraplegia (implicated_via_orthology) | 2.53e-03 | 43 | 186 | 3 | DOID:2476 (implicated_via_orthology) | |
| Disease | obesity (is_implicated_in) | 2.67e-03 | 91 | 186 | 4 | DOID:9970 (is_implicated_in) | |
| Disease | gait measurement | 2.67e-03 | 150 | 186 | 5 | EFO_0007680 | |
| Disease | schizophrenia (is_marker_for) | 2.70e-03 | 44 | 186 | 3 | DOID:5419 (is_marker_for) | |
| Disease | response to beta blocker | 2.88e-03 | 45 | 186 | 3 | EFO_0007766 | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 2.95e-03 | 13 | 186 | 2 | DOID:397 (implicated_via_orthology) | |
| Disease | Mental Retardation, X-Linked Nonsyndromic | 2.95e-03 | 13 | 186 | 2 | C3501611 | |
| Disease | Celiac Disease | 3.26e-03 | 47 | 186 | 3 | C0007570 | |
| Disease | Neuroblastoma | 3.26e-03 | 47 | 186 | 3 | C0027819 | |
| Disease | hypertension (biomarker_via_orthology) | 3.27e-03 | 227 | 186 | 6 | DOID:10763 (biomarker_via_orthology) | |
| Disease | atrial fibrillation (is_implicated_in) | 3.42e-03 | 14 | 186 | 2 | DOID:0060224 (is_implicated_in) | |
| Disease | early cardiac repolarization measurement | 3.42e-03 | 14 | 186 | 2 | EFO_0004885 | |
| Disease | Malignant neoplasm of breast | CEP85L PTPN14 AP1M1 UTP20 ANAPC5 ALK VWF RARA MAP3K6 EGFR MTOR CHD5 EIF5 EHMT1 MACF1 | 3.45e-03 | 1074 | 186 | 15 | C0006142 |
| Disease | myopathy (implicated_via_orthology) | 3.46e-03 | 48 | 186 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | myocardial infarction (biomarker_via_orthology) | 3.52e-03 | 160 | 186 | 5 | DOID:5844 (biomarker_via_orthology) | |
| Disease | pulmonary fibrosis (biomarker_via_orthology) | 3.89e-03 | 50 | 186 | 3 | DOID:3770 (biomarker_via_orthology) | |
| Disease | Proteinuria | 3.93e-03 | 15 | 186 | 2 | HP_0000093 | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 3.93e-03 | 15 | 186 | 2 | DOID:0050646 (implicated_via_orthology) | |
| Disease | Schizophrenia | AMACR ACE DLG3 ALK RARA GRIA2 PRDX6 MAPK14 SLC18A1 MTOR PLA2G4B EIF5 PCK1 | 4.11e-03 | 883 | 186 | 13 | C0036341 |
| Disease | PR interval | MYCBP2 CEP85L MYO3A TFEB TGIF1 SMARCB1 KIAA1755 MACF1 THAP12 | 4.34e-03 | 495 | 186 | 9 | EFO_0004462 |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 4.47e-03 | 16 | 186 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | Major Depressive Disorder | 4.55e-03 | 243 | 186 | 6 | C1269683 | |
| Disease | type 2 diabetes mellitus (is_implicated_in) | 4.67e-03 | 171 | 186 | 5 | DOID:9352 (is_implicated_in) | |
| Disease | Streptozotocin Diabetes | 4.92e-03 | 108 | 186 | 4 | C0038433 | |
| Disease | Diabetes Mellitus, Experimental | 4.92e-03 | 108 | 186 | 4 | C0011853 | |
| Disease | Alloxan Diabetes | 4.92e-03 | 108 | 186 | 4 | C0002152 | |
| Disease | Liver carcinoma | 5.06e-03 | 507 | 186 | 9 | C2239176 | |
| Disease | Myocardial Ischemia | 5.27e-03 | 176 | 186 | 5 | C0151744 | |
| Disease | sphingosine 1-phosphate measurement | 5.66e-03 | 18 | 186 | 2 | EFO_0800185 | |
| Disease | retinal vasculature measurement | 5.73e-03 | 517 | 186 | 9 | EFO_0010554 | |
| Disease | Unipolar Depression | 6.17e-03 | 259 | 186 | 6 | C0041696 | |
| Disease | osteoporosis (implicated_via_orthology) | 6.30e-03 | 19 | 186 | 2 | DOID:11476 (implicated_via_orthology) | |
| Disease | carotid artery disease (is_marker_for) | 6.30e-03 | 19 | 186 | 2 | DOID:3407 (is_marker_for) | |
| Disease | type 1 diabetes mellitus (biomarker_via_orthology) | 6.30e-03 | 19 | 186 | 2 | DOID:9744 (biomarker_via_orthology) | |
| Disease | response to methotrexate, neurotoxicity | 6.30e-03 | 19 | 186 | 2 | EFO_0011057, GO_0031427 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EKGLPILVELLRMDN | 871 | Q99569 | |
| MALDPELLLLRDDGE | 646 | Q8N163 | |
| DFLMSGLPDLLKRQI | 836 | Q96QE3 | |
| PEGLEKMAQLRAELL | 606 | Q86US8 | |
| QPLSLRVGMLGEKLE | 86 | Q6UX73 | |
| LVLEKLVGGADLMLP | 101 | P41214 | |
| SRPNILLLMADDLGI | 36 | P51690 | |
| ELMLGEDTRLPKRLL | 646 | Q8TDI0 | |
| ARGLRSIMEKLLLEP | 561 | O76031 | |
| KDMVGLDALDAQPLL | 586 | P12821 | |
| PGDDIVLMAQALEKL | 111 | Q58F21 | |
| LDKNDMVELLGPRPF | 736 | Q9Y4W6 | |
| GDIRLLMDDLKVLQP | 346 | P33121 | |
| LLEPFRRGVMEKLQL | 76 | Q9UHK6 | |
| REKLVDPQEMLRLLG | 476 | P22570 | |
| PILDLGAEALIMQAR | 451 | Q6NXE6 | |
| EDMLICRLNEFLLPK | 66 | A6NHR8 | |
| GMPELRLGLNDKVLF | 206 | Q9BXS5 | |
| KERVQELPDSGALML | 606 | Q9Y6B7 | |
| LKEELDLMVGIPFNL | 121 | Q9BZ19 | |
| LKGLMPASLRQELED | 911 | Q8N8E3 | |
| PELLKLMCELGNDVI | 461 | Q15057 | |
| RLRLLQMDLTKPGDI | 131 | P80365 | |
| AQLKLMDDLDKVLRP | 986 | Q9P1Y5 | |
| MDLLFGRRKTPEELL | 1 | O43633 | |
| FAMDLPLLKRAGQDL | 11 | Q9NUZ1 | |
| VMDIQLLGQRLKPRD | 156 | Q6GMV1 | |
| NLRAEGLMLEKEPAI | 186 | Q9BYT9 | |
| LRDGNKLAQMEEAPL | 86 | Q13613 | |
| RLLQEGILMHIKPEN | 591 | Q7Z5L2 | |
| FLGPAMQEEALKLVL | 191 | Q9HBD1 | |
| GPAMQEEALKLVLLA | 196 | Q5TC82 | |
| VDDILKKMPLDILRN | 201 | Q6IQ22 | |
| ILNGVRLKVMLADSP | 451 | Q8IUH3 | |
| LLGQMEEEGILRRLK | 56 | P35558 | |
| DRVDMLQEPLLEALK | 346 | P10276 | |
| ALLAEAGIPLEMKRR | 416 | O94810 | |
| LNLEMRKILDLQAPI | 131 | Q4ADV7 | |
| AVRLLLPGQMGKLAE | 141 | Q7Z2G1 | |
| ILSNLVMEELGPELK | 236 | Q96TA1 | |
| PLLANDLMLIKLDES | 111 | Q9Y5K2 | |
| RLLDSMEQDPGALLL | 231 | Q7L1V2 | |
| MAIEPILADGAILDK | 646 | Q9UJX4 | |
| ELAKLMRIEDPSLLN | 511 | Q8IY17 | |
| LMKNKLDPEGLGIIL | 346 | Q9H8M7 | |
| GMRLLPERKQLAILA | 176 | Q9NQZ7 | |
| KEVPGLVLMQDLAFL | 216 | Q3T906 | |
| LKLPRLKLEVMLEDN | 171 | Q9Y6Y0 | |
| DINPLGKKRMDLVLE | 2081 | Q14643 | |
| PLLCREMVELLDKGD | 291 | Q7Z3F1 | |
| KELMEAVLRDPGLLG | 766 | Q5JYT7 | |
| MEILQPLLEQGASLR | 646 | Q13201 | |
| GANPLAVDLLEKMLV | 276 | Q16539 | |
| MLLVDDRALPDFKGI | 91 | Q9H0R4 | |
| MLEDLGFKDLTLQPR | 151 | Q9BYM8 | |
| QERLRPLGLLVAMKE | 256 | Q9NPF0 | |
| KADGMRVILILDPAI | 1306 | O43451 | |
| IIDQLPDLMGLKAVN | 581 | O75197 | |
| DRFILDAPDLGQLMK | 221 | Q8IVV2 | |
| MPNKLLRIQDDGTLL | 141 | P47869 | |
| KAREVLMRLGLDPTQ | 351 | P52789 | |
| LLNAMVAKLGNREDP | 896 | P57737 | |
| EMNKVLLPAKLEVRG | 531 | O95382 | |
| QLDIEGELRRLMAKP | 811 | Q8IY33 | |
| IQMRPDLKGALLSLI | 126 | P42262 | |
| MVANLGELAKLRDLP | 256 | Q53EV4 | |
| PEFRRLGLAAKLMEL | 81 | P61599 | |
| LLMDNLRDKLRPIII | 556 | P26006 | |
| MGKENLEALQRPTLL | 111 | P55157 | |
| LGLLEEMRDDKLAQL | 776 | Q9UKX2 | |
| MAAVLKPVLLGLRDA | 1 | Q9BRP1 | |
| LDLNMSLGQRLKEPR | 521 | Q6NT32 | |
| ALTMPREILQDKDGL | 181 | Q9H6R4 | |
| PALKELLKEALNMER | 311 | Q9UN81 | |
| PINMDGAILLILAIK | 341 | Q0VAA2 | |
| RDVIIDQLPDLMGLK | 196 | A4QPB2 | |
| EVIIDQLPDLMGLKA | 566 | O75581 | |
| PSLMRLDLGELKKLE | 171 | Q9HBW1 | |
| LDVMERADPLFLLIG | 131 | Q9NX47 | |
| QALLERMLSELPALG | 396 | Q9Y4W2 | |
| LRLIEEENMLAPSLK | 241 | Q9UGJ1 | |
| LPLERKAQLAILGMT | 706 | Q1L5Z9 | |
| ELAMPGEDLKFNLIL | 396 | P49411 | |
| GEDLKFNLILRQPMI | 401 | P49411 | |
| EPLMRVELKKEAGLR | 236 | P0C869 | |
| REEMPENVLIGDLLK | 31 | Q9BZA7 | |
| AFLNDLLERMDIGPK | 191 | P56199 | |
| EAKLRLAVVEALGPM | 236 | Q8NDA8 | |
| PRLAAQVLGLLLEKM | 1156 | Q8NDA8 | |
| QVLGLLLEKMSRDVP | 1161 | Q8NDA8 | |
| CDRPEREQLKMLLLA | 81 | Q7Z6Z7 | |
| GLTDRQELKMPLFVL | 16 | P0C7N5 | |
| DLRLALEMLELPQER | 56 | Q8ND30 | |
| TLLKNIGALPVEMAR | 461 | Q9Y2H9 | |
| KRKLMALGPIRLEQD | 5691 | Q9UPN3 | |
| EILILMGKQNIPLDG | 171 | O43422 | |
| MPVKRSLKLDGLLEE | 1 | Q13352 | |
| GLKELPMRNLQEILH | 131 | P00533 | |
| EKLRGDARQKLPMDL | 56 | Q9GZV1 | |
| DARQKLPMDLLVLED | 61 | Q9GZV1 | |
| LPRLLDAKGIILEEM | 2031 | Q3L8U1 | |
| EAERLDVKAMGPLVL | 266 | P55010 | |
| KLLLQINPERELGSM | 2596 | P42858 | |
| GDSELFLMKLINRPI | 371 | Q16658 | |
| PIDLNMLLEVKARAK | 621 | O14981 | |
| EMKLRLLDLENIQIP | 686 | Q96JJ3 | |
| LLRLAVLPEDRLQMK | 31 | Q9P218 | |
| ELVRAKLPAVGALME | 206 | Q5TC63 | |
| KPEDLELLMRRQGLV | 511 | Q96BT3 | |
| LKPLGDNLMEENIRQ | 546 | Q8NHH9 | |
| LEDGIRLPMLDAKQL | 591 | Q5SZL2 | |
| IILGPMKDRVNDDLI | 631 | Q92796 | |
| QLGLAKDPLEEMVPL | 321 | O60307 | |
| RAKKMGLVDQLVEPL | 211 | P40939 | |
| LKDGKPLLNDSRMLL | 181 | Q14CZ8 | |
| LLLMLPLLGTRAQED | 16 | Q16568 | |
| PDLLEMDKNLQGRLF | 181 | Q6PII3 | |
| PPEQLKQLLDLEMRD | 76 | Q6ZQY3 | |
| KQLLDLEMRDSGEPP | 81 | Q6ZQY3 | |
| LPDGMSKLELIDLLA | 616 | Q5TBA9 | |
| GLDNPALLRDMLLAN | 131 | Q5TDH0 | |
| ALKPDVDLLLREMQL | 366 | Q6BAA4 | |
| LKVLFDRMGRILDQP | 636 | Q5W0V3 | |
| LQAGVADDLRKLPFM | 191 | P48728 | |
| GLEKADLLELMPLSE | 141 | Q9H6D7 | |
| LDLMKNLLKLDPADR | 271 | O76039 | |
| RMELADLNKRLPPEA | 446 | Q12770 | |
| LSGMLQERGLPELLV | 126 | P0C264 | |
| AIPLEALRDKALRML | 1801 | P21817 | |
| LQKVLLMLVDGIDPN | 751 | Q9H9B1 | |
| LMGNSLKDEPLLEEL | 96 | Q6UXV1 | |
| PKDSALLRIEIEMLG | 1411 | Q02224 | |
| IDPLELLGKRMDFQI | 691 | B7ZC32 | |
| VARLADDMLEKLPPD | 4356 | Q8TE73 | |
| EPLMNRLEDKCLELV | 236 | Q969Z0 | |
| GIQQDIKELLEPMLA | 496 | P42345 | |
| MLGLLLPNDDLREQV | 286 | A6NES4 | |
| EAPRLAMLQNELEGL | 1131 | Q96Q06 | |
| MDGRVQLIKALLALP | 1 | A6ZKI3 | |
| RAVLGDDPQLMKVAL | 166 | Q9Y6J9 | |
| PLGDKLRPNLEFMLA | 2276 | O75691 | |
| LPEMLGAERGDILRK | 56 | O95399 | |
| PALLGLMADRLEALE | 131 | O15211 | |
| MLLEAPGIFLLGQRK | 41 | Q32P41 | |
| EELMQLLGLSKERKP | 366 | Q32P41 | |
| INDRIKELGMLIPKA | 251 | P19484 | |
| FERKPLLEMNDPELL | 256 | Q969S9 | |
| MKALLDPPLELNSDR | 356 | Q9P0V3 | |
| MIPNLDLNLDRDLVL | 286 | Q8N6T0 | |
| LKVKLLDMGEPRALL | 536 | Q8NDG6 | |
| DEDGLLNLIRTMPGK | 471 | P35251 | |
| DNHGMLLKGEILLLP | 481 | Q8TC59 | |
| PLAIQDLKRMGLKVD | 186 | Q9P2J5 | |
| IKENLEKMGPRILDL | 996 | Q9P2J5 | |
| EKMGPRILDLQLEFD | 1001 | Q9P2J5 | |
| GLDLQACIDLIEKPM | 526 | Q9Y2K3 | |
| RNRELAILLGMLDPA | 106 | P30041 | |
| KNRDEMLVVLPKLDG | 2476 | Q96Q15 | |
| AGLEAQKRPLMLAAL | 856 | Q15678 | |
| IDGRDLMPLLEGKSQ | 421 | P08842 | |
| KLIIMDNLGPEQERD | 1516 | O60292 | |
| LVPIRLDMEIDGQKL | 186 | Q12824 | |
| RGILDAVKEMIPLDL | 826 | O75592 | |
| LKDTGPDELRPMLAQ | 641 | Q8NEZ3 | |
| EDLEKLQMARPNILG | 131 | P13725 | |
| DRIMQLLDVPPGEDK | 516 | Q9NSD9 | |
| PRFILLELMAGGDLK | 1191 | Q9UM73 | |
| LPRKGAQLELEEMLV | 51 | Q9NWT8 | |
| EDFRNGLKLMLLLEV | 71 | Q08043 | |
| SQLPLTERGLRKMLD | 1231 | Q15021 | |
| EILNREKMVDILAGP | 191 | Q96SZ6 | |
| VAMTPALRGKLELLD | 296 | Q96PV4 | |
| RLLPDMLRKDGKDPN | 221 | Q15583 | |
| QMQPLELSEDRLDKL | 6 | O96001 | |
| KDELKDGLRVLIPMD | 2156 | O15417 | |
| DGLRVLIPMDDKLLY | 2161 | O15417 | |
| NRVLSAEALKPGMLL | 176 | Q14690 | |
| MDGQDVQLPLLKGDL | 466 | P04275 | |
| MALERAGKLIENVDP | 116 | Q99747 | |
| EIRMLDNRKLGELPE | 96 | Q12800 | |
| IVNLLPDKGRLMDFL | 366 | Q96DM3 | |
| PDKGRLMDFLLQRKE | 371 | Q96DM3 | |
| LLMPEEARLLAEIGA | 51 | Q9BSV6 | |
| RLDQLLDMPAAGLAV | 36 | Q96A44 | |
| PADMINLRLILVSGK | 6 | O95164 | |
| ALRMDPLEAIQLELD | 226 | Q9H0U9 | |
| ADCQDLLKRLLEPDM | 236 | Q96PN8 | |
| KPLMTELLKRILDGN | 476 | O14787 | |
| EVGKDLPAMLRLLRS | 171 | Q3SY52 | |
| RLIAGPEKRLLEMGL | 156 | Q6XQN6 | |
| RALLGPALKDAMLEL | 91 | P35250 | |
| PKDEVLANRLLNFLM | 2206 | P78527 | |
| LQKAVERGAVPLEML | 166 | P33981 | |
| LNRLKEKLLAEAGMP | 86 | Q8WWH5 | |
| ELIRELGEKLSMEPN | 911 | Q9Y210 | |
| MEAGEEPLLLAELKP | 1 | Q9NYS7 | |
| GELNHLPLKERMVEI | 586 | P17480 | |
| KAIMDFRLVDLPLGL | 1706 | Q14669 | |
| AIRNKMISEGLDPDL | 151 | Q9Y3C0 | |
| EMLRAALLKVLEARP | 46 | Q6ZTW0 | |
| RVLQDLLSEKLPRLM | 761 | Q9BYX2 | |
| MLRTILDAPQRLLKE | 1 | P54219 | |
| DQLMLLERAFIDPLG | 656 | Q9Y3Q0 | |
| PPGILENASDLLRKM | 806 | Q8N1T3 | |
| QKPMGLLSLLDEESR | 781 | Q8NEV4 | |
| DNRPLLDMFLQKPLG | 776 | Q8WXR4 | |
| IKELNSLGRPDILVM | 686 | P22033 |